Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Napo cites breach of contract in termination of agreement with Salix

Nov. 11, 2011

Lundbeck and Otsuka collaborate on products for psychiatric conditions

Nov. 11, 2011

Daiichi Sankyo licenses protein kinase inhibitor from ArQule for phase I development

Nov. 11, 2011

Dako and BMS build on pharmacodiagnostics collaboration

Nov. 10, 2011

Children's Hospital Boston and Pfizer to research muscular dystrophy therapeutics

Nov. 10, 2011

Access Pharmaceuticals signs agreement for RNAi delivery technology

Nov. 10, 2011

Ablynx and Merck Serono enter new Nanobodies collaboration

Nov. 9, 2011

Lilly and Amylin reach agreement to terminate diabetes alliance

Nov. 9, 2011

LivTech and Yakult Honsha enter option agreement for LIV-2008 anticancer program

Nov. 9, 2011

Daiichi Sankyo gains Brazilian rights to drug for overactive bladder

Nov. 8, 2011

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...